Skip to main content
FinSpry Logo
FinSpry
OVID logo
OVID
(NASDAQ)
Ovid Therapeutics Inc.
$2.39-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Ovid Therapeutics (OVID) Stock Price & Financial Analysis

Ovid Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.35 - $2.46
52-Week High$3.11
52-Week Low$0.27
Open$2.40
Volume914.46K
Average Volume (3M)2.38M
Market Cap176.97M
Shares Outstanding73.74M
Price to Sales (P/S)24.40
Price to Book (P/B)1.35
EV/EBITDA-4.20
Revenue (TTM)7.25M
Net Income (TTM)-17.41M
Free Cash Flow (TTM)-38.33M
EPS (TTM)$-0.24
Profit Margin-240.13%
Operating Margin-585.20%
Return on Equity (ROE)-13.33%
Debt to Equity0.10
50-Day MA$2.48
200-Day MA$1.67
52-Week Change823.84%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Ovid Therapeutics

What is the current stock price for OVID?

As of the latest trading session, OVID stock trades at $2.39. The 52-week range is $0.27–$3.11, with a day range of $2.35–$2.46.

What is the P/E ratio for OVID?

The P/E ratio (Price-to-Earnings) for OVID is shown in the Key Statistics section. This valuation metric helps compare Ovid Therapeutics Inc. to industry peers.

Does OVID pay dividends?

Ovid Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for OVID?

Based on 3 analysts, the consensus for OVID is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of OVID?

Ovid Therapeutics's market capitalization is $176.2M, classifying it as a micro-cap company..